Company profile: Centogene
1.1 - Company Overview
Company description
- Provider of methods and technology for human genetics analysis, delivering genetic diagnostic analyses of rare inherited diseases and transforming global genetic data into medical decisions to create broader awareness for patients of all ethnicities around the world.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Centogene
Gnubio
HQ: United States
Website
- Description: Provider of scalable desktop DNA sequencing systems for diagnostic and applied markets, integrating target selection, DNA amplification, sequencing, and analysis via emulsion-based droplet microfluidics. Offers single-use consumable cartridges and workflows for targeted sequencing and hotspot analysis, with whole genome and transcriptome applications in development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gnubio company profile →
Korro Bio
HQ: United States
Website
- Description: Provider of efficient, selective RNA editing solutions leveraging natural processes: OPERA, a platform using oligonucleotides for precise single-base edits to modulate protein function; KRRO-110, an oligonucleotide candidate for Alpha-1 Antitrypsin Deficiency via SERPINA1 RNA editing; and CHORDs, customized high-fidelity oligonucleotides for RNA deamination.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Korro Bio company profile →
C3J Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage bacteriophage therapeutics and a synthetic phage platform to engineer phages for multidrug-resistant infections, including AP-PA02 for Pseudomonas aeruginosa respiratory disease in cystic fibrosis and non-CF bronchiectasis, AP-PA03 for acute pneumonia (hospital-acquired and ventilator-associated), and AP-SA02 for Staphylococcus aureus bacteremia and potential prosthetic joint infections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full C3J Therapeutics company profile →
Floragenex
HQ: United States
Website
- Description: Provider of innovative genomic analysis solutions for human, plant, and animal systems. Oregon-based privately owned biotechnology company delivering results in hundreds of genomics studies since 2007, supporting research in genetics, ecology, evolutionary biology, and biomedical fields.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Floragenex company profile →
Interleukin Genetics
HQ: United States
Website
- Description: Provider of genetic tests for the emerging personalized health market, using applied genetics to empower individuals to personalize their health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Interleukin Genetics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Centogene
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Centogene
2.2 - Growth funds investing in similar companies to Centogene
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Centogene
4.2 - Public trading comparable groups for Centogene
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →